Treatment of medication-related osteonecrosis of the jaw around the dental implant in a patient with multiple myeloma: a case report
Journal of Dental Implant Research · 2020
DOI: 10.54527/jdir.2020.39.4.43 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Dental Implant Research, 2020. Verfasst von Minyeong Youn und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The management of medication-related osteonecrosis of the jaw (MRONJ) around a dental implant is difficult.Conservative treatment is recommended, but patients do not exhibit improvement.Thus, several adjunctive therapies have been introduced.This paper describes a case of MRONJ around a dental implant in a 68-year-old man.Treatment with teriparatide was contraindicated because of the patient's history of multiple myeloma.Successful results with hyperbaric oxygen therapy and surgical intervention were achieved.Clinicians treating patients with MRONJ should conduct a thorough examination before selecting the modalities of adjuvant therapy, thereby establishing a solid treatment strategy.(
Zitieren
APA
Youn, M., Yee, Y., & Kim, J. (2020). Treatment of medication-related osteonecrosis of the jaw around the dental implant in a patient with multiple myeloma: a case report. Journal of Dental Implant Research. https://doi.org/10.54527/jdir.2020.39.4.43
Vancouver
Youn M, Yee Y, Kim J. Treatment of medication-related osteonecrosis of the jaw around the dental implant in a patient with multiple myeloma: a case report. Journal of Dental Implant Research. 2020. doi:10.54527/jdir.2020.39.4.43
BibTeX
@article{Youn2020,
author = {Youn, Minyeong and Yee, Youngjae and Kim, Jun-Young},
title = {Treatment of medication-related osteonecrosis of the jaw around the dental implant in a patient with multiple myeloma: a case report},
journal = {Journal of Dental Implant Research},
year = {2020},
doi = {10.54527/jdir.2020.39.4.43}
}
EUVIMED